FDA Form 483 Highlights Key Compliance Issues at Humacyte Global, Including Microbial Testing Gaps, Delayed OOS Investigations, And Deficiencies in Quality Management; Aims To Address Safety And Quality Concerns Under Federal Food, Drug, And Cosmetic Act

Benzinga · 10/17 19:29